Member Info for 21ATS

From my (admittedly limited) knowledge of what the Good Law Project are doing, it effectively addresses some of this issue David Evans has raised, if not all of them.

Every day I'm seeing and hearing so much conflicting information that it's become difficult to wade through the crap and actually get a grasp on what's happening.

Everything from "It's just a cold" to potentially the worst wave we've had to face. I guess the reality is it's somewhere between these two and we'll only really know in hindsight.

In the meantime I do what I can to keep myself safe and do what I feel is right for me and my family. What else can you do?

My Step daughter is cabin crew on Easyjet. THey seem to be operating fine accoring to her.

They are operating flights way below capacity, but that's simply from no shows. Her flights this week were 30% or so under booked seats, people just chosing not to fly. So far no disruption.

NO.

Next RNS year end results in about 5 weeks time.

Right now he's damned if does, damned if he doesn't.

Who in their right mind would want to step into his shoes today? And what would they do any different?

This genuinely is a no win situation from a political perspective.

Easiest xmas bonus they will ever make.

Investing in a world class diagnostic company selling globally at the beginning of a global pandemic.

They must be laughing their heads off all the way to the bank soon
____________________________________________________________

Reminds me of the scene from The Big Short,

"I'm stood in front of a burning house and I'm offering you fire insurance"

Not going to start discussing again but govt can't dictate the speed of arbitration ( if formal arb) nor could they refuse a court date if that's the route Novacyt decided to go . Hence I said what I did. Furthermore they were in active negotiations and did NOT rollover.
________________________________________________________________________________

They can postpone both arbitration and potential litigation on grounds of public/national interest until a fixed date pending a Judicial review. Fundamenatlly as any litigation would be potentially subject to the findings of said review.

By default, negotiations will also be completely suspended. This has nothing to do with rolling over or playing hardball. NCYT are being dictated to by a higher legal process that has been instigate by neither itself or the Gov. The Good Law Project are actually likely determining the timescale and outcome of the dispute.

I am positive about this company but I'm also realistic about the current situaition it's facing and the potential timescales involved in playing it out to the full.

Agree to a point.
Meanwhile the directors can't buy in because they could subsequently be accused of insider trading if they did.
They know everything about DHSC contractual issues.
How much must that be hurting?
_____________________________________________________

It really is the only explanation that makes any sense. If you look at all the current disputes across all the companies involved it's the same situation - Zero - no updates, no progress - nothing, absolutely nil.

It's existence blocks any director deals as potential insider trading, it precludes any updates of substance that would involved the slightest hint of anything to do with the dispute.

The company probably doesn't wnat to issue RNS's ans every one it issues will be shouted down by "what about the DHSC dispute".

The next material update I expect to be year end trading at the end of Jan and I expect it to be healthy, however we wil likely be no further with the DHSC issue.

Kaeren Said:- Once bitten twice shy , the fact it is still being negotiated means NCYT aren't rolling over and too bloody right.
_________________________________________________________________________________________

That's a big assumption.

I don't feel any negotiation is going on at all. I've said it before and I continue to believe the Gov have pegged all disputed covid stock payments against the GLP Judicial Review and as such have stopped any negotiation or dispute resolution until the JR is complete. They will also likely have blocked any legal action until after the JR has taken place all wrapped up nicely in a non disclosure order.

All this will be done "In public/national interest" to be seen to be ebing above board.

I personally expect no update on the DHSC situation until Q3 2022.

So the main "headline" points I took from this presentation were the following.

Omicrom replicates in the upper respiratory tract as opposed to the lungs.

It is 10 times less virulent than Delta once in the Lungs - so much less agressive.

It is 70 times more transferable then Delta so massively more likely to replicate - hence the spike we're seeing in cases.

So whilst it's clearly less aggressive once in the lungs, the sheer volume of replication is likely to create more problems.

Posted without agenda. I found this informative and interesting.

https://www.youtube.com/watch?v=84XMFVcLScw

Be moved to May 22 so far.

I've gave up any predections of logic a while ago.

We'll probably tank tomorrow as airlines and holiday companies go blue. Not a great deal seems to make much sense at the moment.

Whilst fundamentally correct that the DHSC position is a known to the company accounts, the fact it hangs over the company like a bad smell supressess the share price and will ocntinue to do so all the time it's present.

I was hoping it would have been cleared up this month of the Good Law Product Judicial Review. I'm still convinced it's being pegged to that case as some sort of public interest political excuse. Now that's been delayed till May 22, it could easily hang around for another 6 months. This will stop II's being interested.

If we assume communication from the company is going to continue as it has historically, the next RNS of substance will be end of year accounts early next year. Anything good before that just see it as a bonus.

From a company perspective the only thing a depressed share price does is make it difficult to borrow money, as NCYT doesn't need to borrow money the SP is effectively irrelevant. See the often quoted video from Jeff Bezos re Amazon when it was in this position. The SP is not the company and the company is not the SP.

We know roughly what the revenue will be this year, that can only go up given the current circumstances and recent positive RNS about the PCR approval.

Sit back, relax and wait for things to unfold. Constantly looking at the SP on a minute by minute basis will just make you ill and paranoid, as does reading some of the fruitcake ideas on the BB.

This isn't a punt company, it's not a jam tomorrow company with surprise placings. It has £100M in sales annualy and increasing. It's also not a get rich quick scheme, this is a fantastic medium to long term investment. Treat it as such and your mental health will be in a much better place.

Deos you're like a needy child expecting instant results. Lets give it a few hours /days shall we?

I still see most II's wanting to see a resolution with the DHSC, they simply don't like unkonws, priced in or not, it's just an unknown.

Just bad taste and unnecessary

The RNS this morning got me thinking. Especially the note explaining this particular product was approx 30% of the £3m revenue discussed in the previous RNS.

Are any of the other 10 products awaiting CTDA approval potentially ones that would be replacements for products supplied under the original DHSC contracts?

Could we be waiting for a specific product to be approved to be able to then unlock the dispute via replacement of said approved product?

The only mention I see of Q1 2022 is the poo hitting the fan if they've not been paid and the directors having to raise capital to fill the hole:-

Have I missed somethign suggesting they are expecting to recieve settlement in Q1 22?

DHSC non-payment has, as previously disclosed, put pressure on the Group's cash position. The Group could take action aimed at preserving cash, albeit the Board is reluctant to take such measures, as these would have an adverse impact on the Group's longer term prospects. Given the Board's growth plans for the Group and the likely timing of recovery of any monies due from DHSC, the Board anticipates that a working capital shortfall could arise during Q1 2022 if sufficient amounts from the DHSC are not collected. Certain Directors have indicated that they would be prepared to advance further funding to the Group and the Board is investigating options to raise further capital for the Group. The Board will provide further updates as appropriate.

So May 2022 for the JR.

Lets hope I'm wrong about the wait for that, I just have a gut feeling I'm not.